FAQ

GW 678248

Known as: GW-678248, GW678248 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
01220052016

Related topics

Related topics

2 relations

Broader (2)

NitrilesSulfonamides

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
GW 678248
Sulfonamides
Nitriles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Design, Synthesis, and Biological Evaluation of Novel 2-(Pyridin-3-yloxy)acetamide Derivatives as Potential Anti-HIV-1 Agents.
Through a structure-based molecular hybridization and bioisosterism approach, a series of novel 2-(pyridin-3-yloxy)acetamide… (More)
Is this relevant?
2016
2016
Synthesis and biological evaluation of benzophenone derivatives as potential HIV-1 inhibitors.
BACKGROUND Although a number of agents can achieve high response in acquired immunodeficiency syndrome (AIDS) patients, safer and… (More)
Is this relevant?
2012
2012
Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors.
A series of N-phenylarylformamide derivatives (PAFAs) with anti-wild-type HIV-1 activity (EC(50) values) ranging from 0.3 nM to 5… (More)
Is this relevant?
2010
2010
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease
Current antiretroviral therapy against human immunodeficiency virus (HIV-1) reduces viral load and thereby prevents viral spread… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2010
2010
The disposition and metabolism of GW695634: a non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS.
GW695634 is the prodrug of GW678248, a novel non-nucleoside reverse transcriptase inhibitor with potent antiviral activity… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2008
2008
Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors.
Owing to the emergence of resistant virus, next generation non-nucleoside HIV reverse transcriptase inhibitors (NNRTIs) with… (More)
Is this relevant?
2006
2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor.
Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human… (More)
Is this relevant?
2005
2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor.
The compound GW678248 is a novel benzophenone nonnucleoside reverse transcriptase inhibitor (NNRTI). Preclinical assessment of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro…
GW678248, a novel nonnucleoside reverse transcriptase inhibitor, has been evaluated for anti-human immunodeficiency virus… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?